
PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine
Psychedelics Today
00:00
Do We Need a Special Training for Prescribers?
There's so much data that's being tracked, you know, using c p t codes in particular. And these are like big national surveys of drug use. There is an enormous amount. So we want the therapist to know the treatment approach that was used in the phase three studies. We're actually funding research now with barba rothbom isat emory is doing studies with combining mdma with prolonged exposure. Edna poa, who developed prolonged sures cang to work with ous on a study in israel to combine m d amd a with prolonged Exposure. Is that prolonged exposure during the m d a session, or kind of post session? Well, it's
Transcript
Play full episode